Cargando…

Short-term effect of dopaminergic medication on speech in early-stage Parkinson’s disease

The effect of dopaminergic medication on speech has rarely been examined in early-stage Parkinson’s disease (PD) and the respective literature is inconclusive and limited by inappropriate design with lack of PD control group. The study aims to examine the short-term effect of dopaminergic medication...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tykalova, Tereza, Novotny, Michal, Ruzicka, Evzen, Dusek, Petr, Rusz, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901688/ https://www.ncbi.nlm.nih.gov/pubmed/35256614 http://dx.doi.org/10.1038/s41531-022-00286-y

Ejemplares similares

Distinct patterns of speech disorder in early-onset and late-onset de-novo Parkinson’s disease
por: Rusz, Jan, et al.
Publicado: (2021)

Speech and gait abnormalities in motor subtypes of de‐novo Parkinson's disease
por: Rusz, Jan, et al.
Publicado: (2023)

Articulatory undershoot of vowels in isolated REM sleep behavior disorder and early Parkinson’s disease
por: Skrabal, Dominik, et al.
Publicado: (2022)

Automated video-based assessment of facial bradykinesia in de-novo Parkinson’s disease
por: Novotny, Michal, et al.
Publicado: (2022)

Automated analysis of connected speech reveals early biomarkers of Parkinson’s disease in patients with rapid eye movement sleep behaviour disorder
por: Hlavnička, Jan, et al.
Publicado: (2017)

Speech acoustic indices for differential diagnosis between Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy
por: Daoudi, Khalid, et al.
Publicado: (2022)

Speech Biomarkers in Rapid Eye Movement Sleep Behavior Disorder and Parkinson Disease
por: Rusz, Jan, et al.
Publicado: (2021)

Hypernasality associated with basal ganglia dysfunction: evidence from Parkinson’s disease and Huntington’s disease
por: Novotný, Michal, et al.
Publicado: (2016)

Correction: Objective Acoustic Quantification of Phonatory Dysfunction in Huntington's Disease
por: Rusz, Jan, et al.
Publicado: (2013)

Objective Acoustic Quantification of Phonatory Dysfunction in Huntington's Disease
por: Rusz, Jan, et al.
Publicado: (2013)

Automatic Evaluation of Speech Rhythm Instability and Acceleration in Dysarthrias Associated with Basal Ganglia Dysfunction
por: Rusz, Jan, et al.
Publicado: (2015)

Relations of non-motor symptoms and dopamine transporter binding in REM sleep behavior disorder
por: Dušek, Petr, et al.
Publicado: (2019)

Short- and Long-Term Effects of DBS on Gait in Parkinson's Disease
por: Brozova, Hana, et al.
Publicado: (2021)

Topography of emotional valence and arousal within the motor part of the subthalamic nucleus in Parkinson’s disease
por: Serranová, Tereza, et al.
Publicado: (2019)

Lexical and syntactic deficits analyzed via automated natural language processing: the new monitoring tool in multiple sclerosis
por: Šubert, Martin, et al.
Publicado: (2023)

Unraveling connectivity changes due to dopaminergic therapy in chronically treated Parkinson’s disease patients
por: Ballarini, Tommaso, et al.
Publicado: (2018)

Serum but not cerebrospinal fluid levels of allantoin are increased in de novo Parkinson’s disease
por: Hasíková, Lenka, et al.
Publicado: (2023)

Abnormal Activity in the Precuneus during Time Perception in Parkinson's Disease: An fMRI Study
por: Dušek, Petr, et al.
Publicado: (2012)

Predicting Falls in Parkinson Disease: What Is the Value of Instrumented Testing in OFF Medication State?
por: Hoskovcová, Martina, et al.
Publicado: (2015)

3D visual cueing shortens the double support phase of the gait cycle in patients with advanced Parkinson's disease treated with DBS of the STN
por: Poláková, Kamila, et al.
Publicado: (2020)

The Subthalamic Microlesion Story in Parkinson's Disease: Electrode Insertion-Related Motor Improvement with Relative Cortico-Subcortical Hypoactivation in fMRI
por: Jech, Robert, et al.
Publicado: (2012)

Increased Transferrin Sialylation Predicts Phenoconversion in Isolated REM Sleep Behavior Disorder
por: Ganapathy S., Ranjani, et al.
Publicado: (2022)

Study protocol for using a smartphone application to investigate speech biomarkers of Parkinson’s disease and other synucleinopathies: SMARTSPEECH
por: Kouba, Tomáš, et al.
Publicado: (2022)

Speech Characteristics of Patients with Parkinson's Disease—Does Dopaminergic Medications Have a Role?
por: Vandana, Valiyaparambath Purushothaman, et al.
Publicado: (2021)

Spatial and temporal characteristics of gait as outcome measures in multiple sclerosis (EDSS 0 to 6.5)
por: Lizrova Preiningerova, Jana, et al.
Publicado: (2015)

Erratum: Speech Characteristics of Patients with Parkinson's Disease–Does Dopaminergic Medications Have a Role?
por: Vandana, Valiyaparambath Purushothaman, et al.
Publicado: (2022)

The Instrumental Activities of Daily Living in Parkinson’s Disease Patients Treated by Subthalamic Deep Brain Stimulation
por: Bezdicek, Ondrej, et al.
Publicado: (2022)

Eye Movements in Ephedrone-Induced Parkinsonism
por: Bonnet, Cecilia, et al.
Publicado: (2014)

Basal Ganglia Neuronal Activity during Scanning Eye Movements in Parkinson’s Disease
por: Sieger, Tomáš, et al.
Publicado: (2013)

Physiotherapy in Parkinson's Disease: Building ParkinsonNet in Czechia
por: Gal, Ota, et al.
Publicado: (2017)

The Category of Conventional Physiotherapy: The Case of Parkinson’s Disease Guidelines
por: Hoskovcová, Martina, et al.
Publicado: (2022)

Parkin (PARK 2) Mutations Are Rare in Czech Patients with Early-Onset Parkinson's Disease
por: Fiala, Ondrej, et al.
Publicado: (2014)

Validation of the REM sleep behavior disorder screening questionnaire in the Czech population
por: Bušková, Jitka, et al.
Publicado: (2019)

Separate neural representations of depression, anxiety and apathy in Parkinson’s disease
por: Dan, Rotem, et al.
Publicado: (2017)

Nonmotor Symptoms in Early- and Advanced-Stage Parkinson's Disease Patients on Dopaminergic Therapy: How Do They Correlate with Quality of Life?
por: Valkovic, Peter, et al.
Publicado: (2014)

Weight Gain Is Associated with Medial Contact Site of Subthalamic Stimulation in Parkinson's Disease
por: Růžička, Filip, et al.
Publicado: (2012)

Increased Frequency of Self‐Reported Obsessive‐Compulsive Symptoms in Patients with Functional Movement Disorders
por: Nováková, Lucia, et al.
Publicado: (2023)

Dopaminergic Treatment Effects on Dysarthric Speech: Acoustic Analysis in a Cohort of Patients With Advanced Parkinson's Disease
por: Cavallieri, Francesco, et al.
Publicado: (2021)

Symptom-severity-related brain connectivity alterations in functional movement disorders
por: Mueller, Karsten, et al.
Publicado: (2022)

Prevention of progression in Parkinson’s disease
por: Aaseth, Jan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ts52o2sn1e8dcvqfam5nrut2ss